BioCryst Pharmaceuticals ... (BCRX)
7.33
-0.10 (-1.35%)
At close: Apr 03, 2025, 3:59 PM
8.12
10.78%
Pre-market: Apr 04, 2025, 04:01 AM EDT
13F Institute Ownership
Total Institutes of 268 in BioCryst Pharmaceuticals reduced their positions with a decrease of 1 investors compared to the previous quarter. A reduction of 4.82M shares, as total invested capital declined by $49.59M with ownership percentage dropping from 83.35% to 81.02%.
Options Activity
Institutions are holding more Puts Contracts as Calls Contracts, indicating a bearish sentiment.
Put/Call 1.359
1.36
Call Flow 728,200
42%
Put Flow 989,400
58%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Blackrock, Inc. | 10.68% | 22.1M | +5.64% | 166.16M | < 0.01% |
| Vanguard Group Inc | 10.58% | 21.89M | +7.80% | 164.62M | < 0.01% |
| Avoro Capital Advisors LLC | 5.73% | 11.87M | +0.00% | 89.22M | 1.26% |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.